FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells
Authors
Keywords
Melanoma cells, Melanomas, Metastasis, Wnt signaling cascade, Cancer stem cells, Cancer treatment, Lung and intrathoracic tumors, Tumor stem cells
Journal
PLoS One
Volume 11, Issue 1, Pages e0147638
Publisher
Public Library of Science (PLoS)
Online
2016-01-26
DOI
10.1371/journal.pone.0147638
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frizzled7 Functions as a Wnt Receptor in Intestinal Epithelial Lgr5+ Stem Cells
- (2015) Dustin J. Flanagan et al. Stem Cell Reports
- Wnt7a stimulates myogenic stem cell motility and engraftment resulting in improved muscle strength
- (2014) C. Florian Bentzinger et al. JOURNAL OF CELL BIOLOGY
- WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors
- (2014) Jamie N. Anastas et al. JOURNAL OF CLINICAL INVESTIGATION
- ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling
- (2014) Rumela Chakrabarti et al. NATURE CELL BIOLOGY
- The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells
- (2014) A. Fernandez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ERBB3 is required for metastasis formation of melanoma cells
- (2014) S Tiwary et al. Oncogenesis
- GPR56 Inhibits Melanoma Growth by Internalizing and Degrading Its Ligand TG2
- (2013) L. Yang et al. CANCER RESEARCH
- Mechanisms Governing Metastatic Dormancy and Reactivation
- (2013) Filippo G. Giancotti CELL
- Frizzled 7 Maintains the Undifferentiated State of Human Limbal Stem/Progenitor Cells
- (2013) Hua Mei et al. STEM CELLS
- Dissecting the impact of Frizzled receptors in Wnt/β-catenin signaling of human mesenchymal stem cells
- (2012) Thomas Kolben et al. BIOLOGICAL CHEMISTRY
- The Initial Hours of Metastasis: The Importance of Cooperative Host-Tumor Cell Interactions during Hematogenous Dissemination
- (2012) M. Labelle et al. Cancer Discovery
- GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
- (2011) L. Yang et al. CANCER RESEARCH
- Frizzled7 as an emerging target for cancer therapy
- (2011) Taj D. King et al. CELLULAR SIGNALLING
- Interactions between cancer stem cells and their niche govern metastatic colonization
- (2011) Ilaria Malanchi et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance or sensitivity of Wilms’ tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target
- (2011) N Pode-Shakked et al. ONCOGENE
- The role of mitogen- and stress-activated protein kinase pathways in melanoma
- (2011) Pablo Lopez-Bergami Pigment Cell & Melanoma Research
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Framework models of tumor dormancy from patient-derived observations
- (2010) Christoph A Klein CURRENT OPINION IN GENETICS & DEVELOPMENT
- Ror2/Frizzled Complex Mediates Wnt5a-Induced AP-1 Activation by Regulating Dishevelled Polymerization
- (2010) M. Nishita et al. MOLECULAR AND CELLULAR BIOLOGY
- Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010
- (2010) P. Hersey et al. Pigment Cell & Melanoma Research
- The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
- (2010) E. W. Joseph et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other Cancers
- (2010) Olivia M. Lucero et al. Current Oncology Reports
- Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model
- (2009) Yong-Jing Gao et al. EXPERIMENTAL NEUROLOGY
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
- (2009) Yifang Hu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt
- (2009) Michael P. O’Connell et al. Pigment Cell & Melanoma Research
- Therapeutic Implications of the Cancer Stem Cell Hypothesis
- (2009) Maximilian Diehn et al. SEMINARS IN RADIATION ONCOLOGY
- Wnt/β-catenin signaling: new (and old) players and new insights
- (2008) He Huang et al. CURRENT OPINION IN CELL BIOLOGY
- Melanoma Stem Cells: The Dark Seed of Melanoma
- (2008) Susan E. Zabierowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/β-catenin signaling pathway in hepatocellular carcinoma cells
- (2008) Miran Kim et al. JOURNAL OF HEPATOLOGY
- Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma Metastases
- (2008) L. Xu et al. MOLECULAR CANCER RESEARCH
- Identification of cells initiating human melanomas
- (2008) Tobias Schatton et al. NATURE
- Efficient tumour formation by single human melanoma cells
- (2008) Elsa Quintana et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More